A PHASE 1 OPEN-LABEL CROSSOVER STUDY TO EVALUATE BIOEQUIVALENCE OF ORAL SUSPENSION AND TABLET FORMULATIONS OF PERAMPANEL IN HEALTHY SUBJECTS

被引：0
|
作者：
Laurenza, A. [1 ]
Hall, N. [1 ]
Majid, O. [2 ]
Rege, B. [1 ]
机构：
[1] Eisai Inc, Woodcliff Lake, NJ USA
[2] Eisai Ltd, Hatfield, Herts, England
来源：
EPILEPSIA | 2016年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P561
引用
收藏
页码：170 / 171
页数：2
相关论文
共 50 条
  • [41] Pharmacokinetics and Bioequivalence of Sitagliptin Phosphate/Metformin Hydrochloride Tablets in Healthy Chinese Subjects: A Randomized, Open-Label, Crossover Study
    Shi, Ping
    Liu, Xin
    Li, Ting
    Sun, Fei-fei
    Liu, Yan-ping
    Liu, Shu-qin
    Gao, Xiao-meng
    Ma, Ya-ping
    Fu, Yao
    Cao, Yu
    DRUGS IN R&D, 2022, 22 (01) : 15 - 23
  • [42] Pharmacokinetics and Bioequivalence of Sitagliptin Phosphate/Metformin Hydrochloride Tablets in Healthy Chinese Subjects: A Randomized, Open-Label, Crossover Study
    Ping Shi
    Xin Liu
    Ting Li
    Fei-fei Sun
    Yan-ping Liu
    Shu-qin Liu
    Xiao-meng Gao
    Ya-ping Ma
    Yao Fu
    Yu Cao
    Drugs in R&D, 2022, 22 : 15 - 23
  • [43] Bioequivalence of intramuscular and subcutaneous peginterferon beta-1a: results of a phase I, open-label crossover study in healthy volunteers
    Zhao, Yuan
    Chen, Kun
    Ramia, Nancy
    Sahu, Sangeeta
    Kumar, Achint
    Naylor, Maria L.
    Zhu, Li
    Naik, Himanshu
    Butts, Cherie L.
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2021, 14
  • [44] A randomized, open-label, crossover study to compare the safety and pharmacokinetics of two tablet formulations of tenofovir (tenofovir disoproxil and tenofovir disoproxil fumarate) in healthy subjects
    Yun, Jae Nam
    Yeun, Ji-Sun
    Kan, Hye-Su
    Lee, Minyu
    Kim, Namsick
    Oh, Tae-Young
    Nam, Seung-Kwan
    Choi, Yoon Seok
    Kwon, In Sun
    Hoe, Kwang Lae
    Hong, Jang Hee
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2020, 58 (12) : 749 - 756
  • [45] A Randomized, Open-Label, Crossover Phase 1 Study to Evaluate the Effects of Food on the Pharmacokinetics of a Single Oral Dose of a 15-mg Tylerdipine Tablet in Healthy Chinese Male Volunteers
    Wang, Lu
    Xie, Lijun
    Zhou, Sufeng
    Wang, Yuanyuan
    Chen, Juan
    Zhou, Yanli
    Liu, Yun
    Zhang, Hongwen
    Tao, Mingxue
    Ou, Ning
    Shao, Feng
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2019, 8 (01): : 126 - 132
  • [46] A Single-Dose, Two-Way Crossover, Open-Label Bioequivalence Study of an Amphetamine Extended-Release Oral Suspension in Healthy Adults
    Sikes, Carolyn
    Stark, Jeffrey G.
    McMahen, Russ
    Engelking, Dorothy
    JOURNAL OF ATTENTION DISORDERS, 2020, 24 (03) : 414 - 419
  • [47] Bioequivalence Analysis of Ondansetron Hydrochloride Tablets in Healthy Chinese Subjects: A Randomized, Open-Label, Two-Period Crossover Phase I Study
    Jia, Caiyun
    Zhao, Na
    Song, Haojing
    Hu, Yiting
    Xu, Yufang
    Guo, Caihui
    Bai, Wanjun
    Dong, Zhanjun
    DRUGS IN R&D, 2024, 24 (04) : 531 - 538
  • [48] Pharmacokinetics, bioequivalence, and safety studies of gefitinib tablet formulations: A randomized, open-label, two-period, two-sequence crossover study in Chinese healthy volunteers
    Du, Ping
    Zhao, Zhixia
    Yu, Weiyue
    Zhao, Rui
    Liu, Hongchuan
    Li, Pengfei
    Liu, Lihong
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2023, 84
  • [49] Pharmacokinetics and safety of transdermal and oral granisetron in healthy Chinese subjects: An open-label, randomized, crossover study
    Chen, Rui
    Chen, Xia
    Wang, Hongyun
    Zhong, Wen
    Oh, Eun Sil
    Park, Min Soo
    Kumagai, Yuji
    Zhou, Li
    Nagahama, Fumiko
    Hu, Pei
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2019, 57 (01) : 24 - 31
  • [50] Bioequivalence study of two rosuvastatin tablet formulations in healthy Indonesian subjects
    Harahap, Yahdiana
    Prasaja, Budi
    Azmi, Fahmi
    Lusthom, Windy
    Sinandang, Theresia
    Felicia, Vita
    Yusvita, Lia Yumi
    Panjaitan, Lianna Y.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2016, 54 (03) : 212 - 216
12345